For patients managing neurological conditions, this generic medicine targets specific receptors in the brain. Constricts blood vessels surrounding the brain to ease migraine-related pain and pressure.
Designed to support vascular stabilization to manage acute migraine headaches and alleviate neurological throbbing.
Mechanism of Action
Selectively binds to 5-HT1B and 5-HT1D receptors on intracranial blood vessels, causing vasoconstriction and reducing inflammatory peptide transmission.
Information related to Relpax is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
